| Name | Title | Contact Details |
|---|
Sebacia is a clinical-stage` private medical device company dedicated to creating breakthrough topical therapies for the treatment of dermatological conditions affecting millions of people. Sebacia’s goal is to provide a better alternative to the daily use of topical and systemic drugs currently available for the treatment of acne. Sebacia’s microparticles technology was invented and licensed from Rice University` and the dermatology applications were further developed with researchers from and the Wellman Center of Photomedicine at Massachusetts General Hospital. Sebacia is located in Duluth` Georgia
MedVenture Technology dedicates resources to building a strong community. Employees passionate about a charitable organization are encouraged to share their enthusiasm at work. Volunteers are recruited, donations are accepted, and families all around us
Cadwell is a leading manufacturer and marketer of diagnostic and monitoring products for the world of neurophysiology. We have been proudly serving you since 1979. Visit our online store for all your Electrodes and Accessories needs (US Customers
Our dedicated teams work together to create healthier communities by building strong partnerships. We connect expertise to inspired ideas, products and services while creating a relevant, memorable difference in the lives of our clients, customers and employees. Our dental division provides differentiated products, services and solutions throughout North America. We partner with oral health professionals to create an improved patient experience and practice lifestyle. Our animal health division provides consumable supplies, equipment, software, diagnostic products, vaccines and pharmaceuticals to both companion animal and large animal markets in the U.S. and U.K.
Augmenix, Inc. is a privately held Company based in Waltham, MA focused on the development and commercialization of radiation oncology products using its proprietary hydrogel technology. The company was founded by Incept LLC in 2008 and is funded by several leading venture capital groups.